Aerie Pharmaceuticals, Inc. Operating Cash Flow
Aerie Pharmaceuticals, Inc. reported Operating Cash Flow of $37.28 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-04
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$11.40M.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$13.23M.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was $61.91M.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$30.11M, a 234.65% decline year-over-year.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$99.15M.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$64.69M.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$150.43M.
- Aerie Pharmaceuticals, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$152.58M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 99 month |
|---|---|---|---|---|---|
| 2022-09-30 | -$11.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$24.63M derived: sum of 2 quarters · filed 2022-11-04 | $37.28M 10-Q · filed 2022-11-04 | $7.17M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2022-06-30 | -$13.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $48.68M 10-Q · filed 2022-08-05 | $18.57M derived: sum of 3 quarters · filed 2022-08-05 | -$282.00K derived: sum of 4 quarters · filed 2022-11-04 | |
| 2022-03-31 | $61.91M 10-Q · filed 2022-05-06 | $31.80M derived: sum of 2 quarters · filed 2022-05-06 | $12.95M derived: sum of 3 quarters · filed 2022-11-04 | -$7.19M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-12-31 | -$30.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$48.96M derived: sum of 2 quarters · filed 2022-11-04 | -$69.10M derived: sum of 3 quarters · filed 2022-11-04 | -$99.15M 10-K · filed 2022-02-25 | |
| 2021-09-30 | -$18.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$38.99M derived: sum of 2 quarters · filed 2022-11-04 | -$69.04M 10-Q · filed 2022-11-04 | -$46.68M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | -$20.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$50.19M 10-Q · filed 2022-08-05 | -$27.83M derived: sum of 3 quarters · filed 2022-08-05 | -$50.19M derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | -$30.05M 10-Q · filed 2022-05-06 | -$7.69M derived: sum of 2 quarters · filed 2022-05-06 | -$30.05M derived: sum of 3 quarters · filed 2022-05-06 | -$52.92M derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $22.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $3.00K derived: sum of 2 quarters · filed 2022-02-25 | -$22.87M derived: sum of 3 quarters · filed 2022-02-25 | -$64.69M 10-K · filed 2022-02-25 | |
| 2020-09-30 | -$22.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$45.23M derived: sum of 2 quarters · filed 2021-11-05 | -$87.05M 10-Q · filed 2021-11-05 | -$114.18M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$22.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$64.69M 10-Q · filed 2021-08-05 | -$91.82M derived: sum of 3 quarters · filed 2022-02-25 | -$130.01M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | -$41.82M 10-Q · filed 2021-05-06 | -$68.95M derived: sum of 2 quarters · filed 2022-02-25 | -$107.14M derived: sum of 3 quarters · filed 2022-02-25 | -$143.61M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | -$27.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$65.32M derived: sum of 2 quarters · filed 2022-02-25 | -$101.79M derived: sum of 3 quarters · filed 2022-02-25 | -$150.43M 10-K · filed 2022-02-25 | |
| 2019-09-30 | -$38.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$74.67M derived: sum of 2 quarters · filed 2020-11-06 | -$123.31M 10-Q · filed 2020-11-06 | -$154.82M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$36.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$85.11M 10-Q · filed 2020-08-07 | -$116.62M derived: sum of 3 quarters · filed 2021-02-26 | -$159.89M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$48.64M 10-Q · filed 2020-05-07 | -$80.15M derived: sum of 2 quarters · filed 2021-02-26 | -$123.42M derived: sum of 3 quarters · filed 2021-02-26 | -$160.38M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | -$31.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$74.78M derived: sum of 2 quarters · filed 2021-02-26 | -$111.74M derived: sum of 3 quarters · filed 2021-02-26 | -$152.58M 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$43.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$80.23M derived: sum of 2 quarters · filed 2019-11-07 | -$121.06M 10-Q · filed 2019-11-07 | -$147.21M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | -$36.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$77.80M 10-Q · filed 2019-08-08 | -$103.95M derived: sum of 3 quarters · filed 2020-02-24 | -$125.23M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | -$40.84M 10-Q · filed 2019-05-08 | -$66.98M derived: sum of 2 quarters · filed 2020-02-24 | -$88.26M derived: sum of 3 quarters · filed 2020-02-24 | -$109.19M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | -$26.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$47.43M derived: sum of 2 quarters · filed 2020-02-24 | -$68.36M derived: sum of 3 quarters · filed 2020-02-24 | -$93.21M 10-K · filed 2020-02-24 | |
| 2017-09-30 | -$21.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$42.21M derived: sum of 2 quarters · filed 2018-11-07 | -$67.06M 10-Q · filed 2018-11-07 | -$85.91M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$20.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$45.79M 10-Q · filed 2018-08-09 | -$64.63M derived: sum of 3 quarters · filed 2019-03-01 | -$85.79M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$24.85M 10-Q · filed 2018-05-09 | -$43.70M derived: sum of 2 quarters · filed 2019-03-01 | -$64.86M derived: sum of 3 quarters · filed 2019-03-01 | -$85.34M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$18.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$40.01M derived: sum of 2 quarters · filed 2019-03-01 | -$60.48M derived: sum of 3 quarters · filed 2019-03-01 | -$79.84M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$21.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$41.64M derived: sum of 2 quarters · filed 2017-11-09 | -$60.99M 10-Q · filed 2017-11-09 | -$75.23M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | -$20.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$39.83M 10-Q · filed 2017-08-03 | -$54.07M derived: sum of 3 quarters · filed 2018-03-01 | ||
| 2016-03-31 | -$19.36M 10-Q · filed 2017-05-03 | -$33.59M derived: sum of 2 quarters · filed 2018-03-01 | |||
| 2015-12-31 | -$14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$55.75M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | -$41.51M 10-Q · filed 2016-11-03 | ||||
| 2014-12-31 | -$33.73M 10-K · filed 2017-03-09 | ||||
| 2013-09-30 | -$11.57M 10-Q · filed 2013-12-05 | -$70.43M 10-Q · filed 2013-12-05 | |||
| 2012-09-30 | -$11.95M 10-Q · filed 2013-12-05 |